Market Research Logo

Antiemetic Drugs

Antiemetic Drugs

Antiemetic Drugs market worldwide is projected to grow by US$2.2 Billion, driven by a compounded growth of 6.2%. Chemotherapy, one of the segments analyzed and sized in this study, displays the potential to grow at over 6.8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$3.1 Billion by the year 2025, Chemotherapy will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 7.1% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$101.2 Million to the region's size and clout in the next 5 to 6 years. Over US$103.6 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Chemotherapy will reach a market size of US$258.1 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 6% over the next couple of years and add approximately US$381.2 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Abbott Laboratories, Inc.; Astellas Pharma, Inc.; Baxter International, Inc.; Cipla Ltd.; GlaxoSmithKline PLC; Johnson & Johnson; Merck & Co., Inc.; Novartis AG; Pfizer, Inc.; Sanofi-aventis U.S. LLC

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Antiemetic Drugs Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Antiemetic Drugs Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 2: Antiemetic Drugs Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
TABLE 3: Antiemetic Drugs Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
TABLE 4: Chemotherapy (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025
TABLE 5: Chemotherapy (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
TABLE 6: Chemotherapy (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025
TABLE 7: Gastroenteritis (Application) Worldwide Sales in US$ Million by Region/Country: 2018-2025
TABLE 8: Gastroenteritis (Application) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017
TABLE 9: Gastroenteritis (Application) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025
TABLE 10: Surgery (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 11: Surgery (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017
TABLE 12: Surgery (Application) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
TABLE 13: Other Applications (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025
TABLE 14: Other Applications (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
TABLE 15: Other Applications (Application) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Antiemetic Drugs Market Share (in %) by Company: 2019 & 2025
TABLE 16: United States Antiemetic Drugs Latent Demand Forecasts in US$ Million by Application: 2018 to 2025
TABLE 17: Antiemetic Drugs Historic Demand Patterns in the United States by Application in US$ Million for 2009-2017
TABLE 18: Antiemetic Drugs Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025
CANADA
TABLE 19: Canadian Antiemetic Drugs Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025
TABLE 20: Antiemetic Drugs Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017
TABLE 21: Canadian Antiemetic Drugs Market Share Analysis by Application: 2009 VS 2019 VS 2025
JAPAN
TABLE 22: Japanese Demand Estimates and Forecasts for Antiemetic Drugs in US$ Million by Application: 2018 to 2025
TABLE 23: Japanese Antiemetic Drugs Market in US$ Million by Application: 2009-2017
TABLE 24: Antiemetic Drugs Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025
CHINA
TABLE 25: Chinese Demand for Antiemetic Drugs in US$ Million by Application: 2018 to 2025
TABLE 26: Antiemetic Drugs Market Review in China in US$ Million by Application: 2009-2017
TABLE 27: Chinese Antiemetic Drugs Market Share Breakdown by Application: 2009 VS 2019 VS 2025
EUROPE
Market Facts & Figures
European Antiemetic Drugs Market: Competitor Market Share Scenario (in %) for 2019 & 2025
TABLE 28: European Antiemetic Drugs Market Demand Scenario in US$ Million by Region/Country: 2018-2025
TABLE 29: Antiemetic Drugs Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
TABLE 30: European Antiemetic Drugs Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
TABLE 31: European Antiemetic Drugs Addressable Market Opportunity in US$ Million by Application: 2018-2025
TABLE 32: Antiemetic Drugs Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017
TABLE 33: European Antiemetic Drugs Market Share Analysis by Application: 2009 VS 2019 VS 2025
FRANCE
TABLE 34: Antiemetic Drugs Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025
TABLE 35: French Antiemetic Drugs Historic Market Review in US$ Million by Application: 2009-2017
TABLE 36: French Antiemetic Drugs Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025
GERMANY
TABLE 37: Antiemetic Drugs Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025
TABLE 38: German Antiemetic Drugs Market in Retrospect in US$ Million by Application: 2009-2017
TABLE 39: Antiemetic Drugs Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025
ITALY
TABLE 40: Italian Demand for Antiemetic Drugs in US$ Million by Application: 2018 to 2025
TABLE 41: Antiemetic Drugs Market Review in Italy in US$ Million by Application: 2009-2017
TABLE 42: Italian Antiemetic Drugs Market Share Breakdown by Application: 2009 VS 2019 VS 2025
UNITED KINGDOM
TABLE 43: United Kingdom Demand Estimates and Forecasts for Antiemetic Drugs in US$ Million by Application: 2018 to 2025
TABLE 44: United Kingdom Antiemetic Drugs Market in US$ Million by Application: 2009-2017
TABLE 45: Antiemetic Drugs Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025
REST OF EUROPE
TABLE 46: Rest of Europe Antiemetic Drugs Addressable Market Opportunity in US$ Million by Application: 2018-2025
TABLE 47: Antiemetic Drugs Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017
TABLE 48: Rest of Europe Antiemetic Drugs Market Share Analysis by Application: 2009 VS 2019 VS 2025
ASIA-PACIFIC
TABLE 49: Antiemetic Drugs Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025
TABLE 50: Asia-Pacific Antiemetic Drugs Historic Market Review in US$ Million by Application: 2009-2017
TABLE 51: Asia-Pacific Antiemetic Drugs Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025
REST OF WORLD
TABLE 52: Rest of World Antiemetic Drugs Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025
TABLE 53: Antiemetic Drugs Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017
TABLE 54: Rest of World Antiemetic Drugs Market Share Analysis by Application: 2009 VS 2019 VS 2025
IV. COMPETITION
ABBOTT LABORATORIES
ASTELLAS PHARMA
BAXTER INTERNATIONAL
CIPLA
GLAXOSMITHKLINE PLC
JOHNSON & JOHNSON
MERCK & CO.
NOVARTIS AG
PFIZER
SANOFI-AVENTIS US
V. CURATED RESEARCH

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook